A Hawaiian woman, 37, was diagnosed with a rare instance of three overlapping neurological conditions caused by the body's ...

Explore the growing U.S. Zilbrysq (Zilucoplan) market, projected to expand at a CAGR of 21.64% post-FDA approval for anti-AChR antibody-positive generalized myasthenia gravis (gMG). The subcutaneous ...